Halozyme Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 13.27 M | $1.04 B | 0.05% | 11.23% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 5.35 M | $418.85 M | 1.52% | 4.53% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 5.30 M | $414.75 M | 0.95% | 4.49% |
| STATE STREET CORP | 08/07/2026 | 5.18 M | $405.38 M | 4.89% | 4.38% |
| INVESCO LTD. | 08/14/2026 | 3.18 M | $248.74 M | -20.80% | 2.69% |
| MORGAN STANLEY | 08/13/2026 | 2.83 M | $221.71 M | 10.55% | 2.40% |
| BOSTON PARTNERS | 08/04/2026 | 2.77 M | $216.82 M | 3.35% | 2.35% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 2.74 M | $214.50 M | -5.92% | 2.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.52 M | $197.28 M | 0.57% | 2.13% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 2.51 M | $196.54 M | -0.59% | 2.13% |
| SNYDER CAPITAL MANAGEMENT L P | 08/13/2026 | 2.40 M | $187.54 M | 3.14% | 2.03% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 2.09 M | $163.54 M | 0.47% | 1.77% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 2.01 M | $157.05 M | 7.37% | 1.70% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.94 M | $151.69 M | 180.91% | 1.64% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 08/13/2026 | 1.81 M | $141.73 M | 12.43% | 1.53% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 1.70 M | $133.42 M | -11.13% | 1.44% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 1.70 M | $109.65 M | -2.30% | 1.44% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.65 M | $129.40 M | 4.31% | 1.40% |
| UBS GROUP AG | 08/13/2026 | 1.49 M | $116.80 M | 63.26% | 1.26% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 08/12/2026 | 1.49 M | $116.70 M | 1.76% | 1.26% |
| NORGES BANK | 08/12/2026 | 1.48 M | $116.13 M | 100.00% | 1.26% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 1.42 M | $110.91 M | -4.40% | 1.20% |
| LSV ASSET MANAGEMENT | 08/06/2026 | 1.41 M | $110.38 M | 2.82% | 1.19% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 07/29/2026 | 1.39 M | $109.02 M | 14.29% | 1.18% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 1.39 M | $108.83 M | -9.46% | 1.18% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 1.35 M | $105.97 M | -2.87% | 1.15% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.35 M | $105.57 M | 100.00% | 1.14% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.32 M | $103.52 M | 2.57% | 1.12% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.32 M | $103.52 M | 100.00% | 1.12% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.27 M | $99.43 M | 73.99% | 1.08% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.24 M | $97.37 M | 7.52% | 1.05% |
| CONGRESS ASSET MANAGEMENT CO /MA | 07/07/2026 | 1.23 M | $96.20 M | -4.02% | 1.04% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 1.18 M | $92.66 M | -0.27% | 1.00% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 1.12 M | $87.33 M | -4.53% | 0.94% |
| EPOCH INVESTMENT PARTNERS, INC. | 08/13/2026 | 1.10 M | $85.98 M | -3.50% | 0.93% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.09 M | $85.13 M | -2.13% | 0.92% |
| BOSTON TRUST WALDEN CORP | 07/24/2026 | 1.08 M | $84.77 M | 59.38% | 0.92% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 08/14/2026 | 1.07 M | $83.94 M | -4.35% | 0.91% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 997.64 K | $78.09 M | 4,578.94% | 0.84% |
| FEDERATED HERMES, INC. | 08/12/2026 | 962.04 K | $75.30 M | -14.35% | 0.81% |
| BANK OF MONTREAL /CAN/ | 08/12/2026 | 942.43 K | $73.76 M | -10.72% | 0.80% |
| MIZUHO MARKETS CAYMAN LP | 07/24/2026 | 834.50 K | $65.32 M | 100.00% | 0.71% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 802.25 K | $62.79 M | -18.46% | 0.68% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 785.56 K | $61.49 M | -22.71% | 0.66% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 765.69 K | $59.93 M | 2.45% | 0.65% |
| GOTHAM ASSET MANAGEMENT, LLC | 08/14/2026 | 739.27 K | $57.86 M | -1.01% | 0.63% |
| JANE STREET GROUP, LLC | 08/14/2026 | 694.68 K | $54.37 M | -16.47% | 0.59% |
| HANDELSBANKEN FONDER AB | 07/10/2026 | 631.90 K | $49.46 M | 28.05% | 0.53% |
| SEI INVESTMENTS CO | 08/14/2026 | 551.12 K | $43.14 M | 20.39% | 0.47% |
| ROYAL BANK OF CANADA | 08/14/2026 | 545.76 K | $42.72 M | -17.09% | 0.46% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Halozyme Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 931 institutional investors and hedge funds held shares of Halozyme Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 13.27 M
VANGUARD CAPITAL MANAGEMENT LLC: 5.35 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 5.3 M
STATE STREET CORP: 5.18 M
Invesco Ltd.: 3.18 M
MORGAN STANLEY: 2.83 M
105.31% of Halozyme Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 190.28 M shares in the last 24 months. This purchase volume represents approximately $12.97 B in transactions.